Memorial Sloan-Kettering to use Sutro's cell-free protein synthesis technology ... News-Medical.net Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration agreement with ... Sutro Biopharma to Collaborate With Memorial Sloan-Kettering Cancer Center to ... Memorial Sloan-Kettering to Use Sutro Technology for Neuroblastoma Research |
